GlassScriptPhysician profile
Peter W Wong
NPI 1922157999
$7,441.60
in general payments reported to CMS, 2019-2025
41 companies · $898 in 2025
The $898 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $984 · 2020: $592 · 2021: $1,264 · 2022: $1,247 · 2023: $1,012 · 2024: $1,445 · 2025: $898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,354.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,063.61 | 2019-2025 | Rinvoq, Skyrizi, Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $1,171.36 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Janssen Biotech, INC. | $695.61 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $672.74 | 2019-2025 | Xifaxan |
| Pfizer INC. | $330.03 | 2019-2025 | |
| Qol Medical, LLC | $318.62 | 2019-2025 | Sucraid, Sucraid |
| E.R. Squibb & Sons, L.L.C. | $253.87 | 2023-2024 | Zeposia |
| Gilead Sciences, INC. | $211.04 | 2020-2025 | |
| Phathom Pharmaceuticals, INC. | $160.16 | 2024-2025 | Voquezna |
| Ardelyx, INC. | $156.78 | 2023-2025 | Ibsrela |
| Medtronic, INC. | $115.00 | 2022 | |
| Nestle Healthcare Nutrition INC. | $101.30 | 2021-2023 | |
| Celgene Corporation | $100.42 | 2021-2023 | Zeposia |
| Cook Medical LLC | $99.75 | 2020 | |
| Genzyme Corporation | $93.54 | 2023-2025 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.